<DOC>
	<DOC>NCT02826252</DOC>
	<brief_summary>The aim of this study is to examine inhalation behavior in patients enrolled in the German Ventavis patient support program Ventaplus when these patients are switched from Ventavis (Iloprost) 10 μg/mL to Ventavis (Iloprost) 20 μg/mL formulation.</brief_summary>
	<brief_title>Examination of Ventavis (Iloprost) Inhalation Behavior Using the I-Neb AAD System in Patients With Pulmonary Arterial Hypertension When Switching the Iloprost Nebulizer Solution for Inhalation From 10 μg/mL (V10) to 20 μg/mL (V20)</brief_title>
	<detailed_description>The VENTASWITCH study will be a local, prospective and retrospective, observational, case-crossover study. Data are collected and downloaded from the I-Neb AAD (Adaptive Aerosol Delivery) System. Two data collection periods are planned: period one; data collection from the last 3 months using Ventavis (Iloprost) 10 μg/mL (V10) before the index date of switching to Ventavis (Iloprost) 20 μg/mL (V20) (retrospective part) and period two; data collection for 3 months using V20 from index date (prospective part).</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Respiratory Aspiration</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Hypertension, Pulmonary</mesh_term>
	<mesh_term>Iloprost</mesh_term>
	<criteria>Patients aged ≥18 years at time of signing informed consent. Patients, diagnosed with group 1 PAH. Patients must be enrolled in the German Ventavis patient support program Ventaplus. Patients who either already switched from V10 to V20 therapy or who agreed to do so according to their physician's decision. Patients must have been on V10 therapy for at least 2 weeks. Written informed consent must be obtained. participation in other clinical or interventional study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Pulmonary Arterial Hypertension (PAH)</keyword>
</DOC>